nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.137	0.251	CbGbCtD
Levothyroxine—CYP2C8—Progesterone—uterine cancer	0.0911	0.167	CbGbCtD
Levothyroxine—ABCB1—Progesterone—uterine cancer	0.0616	0.113	CbGbCtD
Levothyroxine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0558	0.102	CbGbCtD
Levothyroxine—ABCB1—Dactinomycin—uterine cancer	0.0489	0.0894	CbGbCtD
Levothyroxine—CYP2C8—Etoposide—uterine cancer	0.0408	0.0746	CbGbCtD
Levothyroxine—CYP3A4—Progesterone—uterine cancer	0.0369	0.0676	CbGbCtD
Levothyroxine—ABCB1—Etoposide—uterine cancer	0.0276	0.0505	CbGbCtD
Levothyroxine—ABCB1—Doxorubicin—uterine cancer	0.0188	0.0344	CbGbCtD
Levothyroxine—Choking—Progesterone—uterine cancer	0.0169	0.0774	CcSEcCtD
Levothyroxine—CYP3A4—Etoposide—uterine cancer	0.0165	0.0302	CbGbCtD
Levothyroxine—Infertility—Progesterone—uterine cancer	0.0118	0.0542	CcSEcCtD
Levothyroxine—CYP3A4—Doxorubicin—uterine cancer	0.0113	0.0206	CbGbCtD
Levothyroxine—Benign intracranial hypertension—Medroxyprogesterone Acetate—uterine cancer	0.00953	0.0436	CcSEcCtD
Levothyroxine—Hyperthyroidism—Medroxyprogesterone Acetate—uterine cancer	0.00709	0.0324	CcSEcCtD
Levothyroxine—Menstruation irregular—Progesterone—uterine cancer	0.00558	0.0255	CcSEcCtD
Levothyroxine—Menstruation irregular—Medroxyprogesterone Acetate—uterine cancer	0.00506	0.0231	CcSEcCtD
Levothyroxine—SLC16A2—myometrium—uterine cancer	0.00466	0.0329	CbGeAlD
Levothyroxine—SLC7A5—myometrium—uterine cancer	0.00393	0.0277	CbGeAlD
Levothyroxine—SLCO4C1—renal system—uterine cancer	0.00391	0.0276	CbGeAlD
Levothyroxine—SLCO4C1—endometrium—uterine cancer	0.00378	0.0266	CbGeAlD
Levothyroxine—THRB—renal system—uterine cancer	0.00375	0.0264	CbGeAlD
Levothyroxine—THRA—renal system—uterine cancer	0.00375	0.0264	CbGeAlD
Levothyroxine—SLCO4C1—mammalian vulva—uterine cancer	0.00366	0.0258	CbGeAlD
Levothyroxine—SLC16A2—uterine cervix—uterine cancer	0.00363	0.0256	CbGeAlD
Levothyroxine—SLCO4A1—myometrium—uterine cancer	0.00343	0.0242	CbGeAlD
Levothyroxine—SLC16A2—endometrium—uterine cancer	0.00328	0.0231	CbGeAlD
Levothyroxine—SLCO1C1—renal system—uterine cancer	0.00312	0.022	CbGeAlD
Levothyroxine—SLC7A5—epithelium—uterine cancer	0.00308	0.0217	CbGeAlD
Levothyroxine—SLC7A5—uterine cervix—uterine cancer	0.00306	0.0216	CbGeAlD
Levothyroxine—SLC16A2—uterus—uterine cancer	0.00303	0.0213	CbGeAlD
Levothyroxine—THRA—female reproductive system—uterine cancer	0.003	0.0212	CbGeAlD
Levothyroxine—THRB—female reproductive system—uterine cancer	0.003	0.0212	CbGeAlD
Levothyroxine—SLC7A5—smooth muscle tissue—uterine cancer	0.00297	0.0209	CbGeAlD
Levothyroxine—SLC7A5—decidua—uterine cancer	0.00291	0.0205	CbGeAlD
Levothyroxine—SLCO4C1—vagina—uterine cancer	0.00283	0.02	CbGeAlD
Levothyroxine—TTR—renal system—uterine cancer	0.00279	0.0196	CbGeAlD
Levothyroxine—SLC7A5—endometrium—uterine cancer	0.00276	0.0195	CbGeAlD
Levothyroxine—SLCO1B3—vagina—uterine cancer	0.00275	0.0194	CbGeAlD
Levothyroxine—THRA—female gonad—uterine cancer	0.00273	0.0193	CbGeAlD
Levothyroxine—THRB—female gonad—uterine cancer	0.00273	0.0193	CbGeAlD
Levothyroxine—THRB—vagina—uterine cancer	0.00271	0.0191	CbGeAlD
Levothyroxine—SLC7A5—mammalian vulva—uterine cancer	0.00267	0.0189	CbGeAlD
Levothyroxine—SLC7A5—uterus—uterine cancer	0.00255	0.018	CbGeAlD
Levothyroxine—SLCO4A1—decidua—uterine cancer	0.00254	0.0179	CbGeAlD
Levothyroxine—Disorientation—Progesterone—uterine cancer	0.00251	0.0115	CcSEcCtD
Levothyroxine—SLCO4A1—renal system—uterine cancer	0.0025	0.0176	CbGeAlD
Levothyroxine—SLC16A2—female gonad—uterine cancer	0.00247	0.0174	CbGeAlD
Levothyroxine—SLC16A2—vagina—uterine cancer	0.00246	0.0173	CbGeAlD
Levothyroxine—SLCO4A1—endometrium—uterine cancer	0.00241	0.017	CbGeAlD
Levothyroxine—Increased appetite—Progesterone—uterine cancer	0.00239	0.0109	CcSEcCtD
Levothyroxine—SLCO4A1—mammalian vulva—uterine cancer	0.00234	0.0165	CbGeAlD
Levothyroxine—SLC7A5—female reproductive system—uterine cancer	0.00229	0.0161	CbGeAlD
Levothyroxine—Cardiac failure congestive—Medroxyprogesterone Acetate—uterine cancer	0.00224	0.0103	CcSEcCtD
Levothyroxine—TTR—female reproductive system—uterine cancer	0.00223	0.0157	CbGeAlD
Levothyroxine—Affect lability—Progesterone—uterine cancer	0.00221	0.0101	CcSEcCtD
Levothyroxine—SLCO1B1—renal system—uterine cancer	0.0022	0.0155	CbGeAlD
Levothyroxine—Increased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00216	0.0099	CcSEcCtD
Levothyroxine—Irritability—Progesterone—uterine cancer	0.00214	0.0098	CcSEcCtD
Levothyroxine—Mood swings—Progesterone—uterine cancer	0.00213	0.00972	CcSEcCtD
Levothyroxine—SLC7A5—female gonad—uterine cancer	0.00208	0.0147	CbGeAlD
Levothyroxine—Hypoglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00208	0.00953	CcSEcCtD
Levothyroxine—SLC7A5—vagina—uterine cancer	0.00207	0.0146	CbGeAlD
Levothyroxine—Affect lability—Medroxyprogesterone Acetate—uterine cancer	0.002	0.00915	CcSEcCtD
Levothyroxine—SLCO4A1—female reproductive system—uterine cancer	0.002	0.0141	CbGeAlD
Levothyroxine—Irritability—Medroxyprogesterone Acetate—uterine cancer	0.00194	0.00888	CcSEcCtD
Levothyroxine—Dysphagia—Progesterone—uterine cancer	0.00194	0.00887	CcSEcCtD
Levothyroxine—Mood swings—Medroxyprogesterone Acetate—uterine cancer	0.00193	0.00881	CcSEcCtD
Levothyroxine—Sweating increased—Progesterone—uterine cancer	0.00189	0.00864	CcSEcCtD
Levothyroxine—Angina pectoris—Progesterone—uterine cancer	0.00189	0.00864	CcSEcCtD
Levothyroxine—SLCO4A1—vagina—uterine cancer	0.00181	0.0128	CbGeAlD
Levothyroxine—Muscular weakness—Medroxyprogesterone Acetate—uterine cancer	0.00179	0.0082	CcSEcCtD
Levothyroxine—SLCO1A2—renal system—uterine cancer	0.00179	0.0126	CbGeAlD
Levothyroxine—SLCO1B1—female reproductive system—uterine cancer	0.00176	0.0124	CbGeAlD
Levothyroxine—Dysphagia—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.00804	CcSEcCtD
Levothyroxine—THRA—lymph node—uterine cancer	0.00176	0.0124	CbGeAlD
Levothyroxine—THRB—lymph node—uterine cancer	0.00176	0.0124	CbGeAlD
Levothyroxine—Weight decreased—Progesterone—uterine cancer	0.00175	0.00802	CcSEcCtD
Levothyroxine—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.00171	0.00783	CcSEcCtD
Levothyroxine—Body temperature increased—Carboplatin—uterine cancer	0.00166	0.00759	CcSEcCtD
Levothyroxine—SLC16A2—lymph node—uterine cancer	0.00159	0.0112	CbGeAlD
Levothyroxine—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.00159	0.00727	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.00706	CcSEcCtD
Levothyroxine—Myocardial infarction—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.00702	CcSEcCtD
Levothyroxine—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.0015	0.00687	CcSEcCtD
Levothyroxine—SLCO1C1—lymph node—uterine cancer	0.00146	0.0103	CbGeAlD
Levothyroxine—Alopecia—Progesterone—uterine cancer	0.00137	0.00627	CcSEcCtD
Levothyroxine—Dysphagia—Dactinomycin—uterine cancer	0.00137	0.00627	CcSEcCtD
Levothyroxine—SLC7A5—lymph node—uterine cancer	0.00134	0.00945	CbGeAlD
Levothyroxine—Tension—Progesterone—uterine cancer	0.00133	0.00606	CcSEcCtD
Levothyroxine—Nervousness—Progesterone—uterine cancer	0.00131	0.006	CcSEcCtD
Levothyroxine—Tremor—Progesterone—uterine cancer	0.00127	0.00579	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Etoposide—uterine cancer	0.00127	0.00579	CcSEcCtD
Levothyroxine—CYP2C8—renal system—uterine cancer	0.00125	0.00881	CbGeAlD
Levothyroxine—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00569	CcSEcCtD
Levothyroxine—Angioedema—Progesterone—uterine cancer	0.00123	0.00565	CcSEcCtD
Levothyroxine—CYP2C8—endometrium—uterine cancer	0.00121	0.00852	CbGeAlD
Levothyroxine—Tension—Medroxyprogesterone Acetate—uterine cancer	0.0012	0.0055	CcSEcCtD
Levothyroxine—Palpitations—Progesterone—uterine cancer	0.00119	0.00546	CcSEcCtD
Levothyroxine—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00544	CcSEcCtD
Levothyroxine—Cardiac failure—Etoposide—uterine cancer	0.00118	0.00538	CcSEcCtD
Levothyroxine—Convulsion—Progesterone—uterine cancer	0.00117	0.00535	CcSEcCtD
Levothyroxine—SLCO4A1—lymph node—uterine cancer	0.00117	0.00825	CbGeAlD
Levothyroxine—Arthralgia—Progesterone—uterine cancer	0.00115	0.00526	CcSEcCtD
Levothyroxine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.00525	CcSEcCtD
Levothyroxine—Anxiety—Progesterone—uterine cancer	0.00115	0.00524	CcSEcCtD
Levothyroxine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00113	0.00515	CcSEcCtD
Levothyroxine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00512	CcSEcCtD
Levothyroxine—Confusional state—Progesterone—uterine cancer	0.00111	0.00509	CcSEcCtD
Levothyroxine—Cardiac arrest—Etoposide—uterine cancer	0.00109	0.00499	CcSEcCtD
Levothyroxine—Shock—Progesterone—uterine cancer	0.00109	0.00496	CcSEcCtD
Levothyroxine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00495	CcSEcCtD
Levothyroxine—Tachycardia—Progesterone—uterine cancer	0.00108	0.00492	CcSEcCtD
Levothyroxine—Hyperhidrosis—Progesterone—uterine cancer	0.00107	0.00488	CcSEcCtD
Levothyroxine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00485	CcSEcCtD
Levothyroxine—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00477	CcSEcCtD
Levothyroxine—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00475	CcSEcCtD
Levothyroxine—Flushing—Dactinomycin—uterine cancer	0.00102	0.00466	CcSEcCtD
Levothyroxine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00461	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Progesterone—uterine cancer	0.001	0.0046	CcSEcCtD
Levothyroxine—CYP2C8—female reproductive system—uterine cancer	0.001	0.00705	CbGeAlD
Levothyroxine—Insomnia—Progesterone—uterine cancer	0.000997	0.00456	CcSEcCtD
Levothyroxine—Dysphagia—Etoposide—uterine cancer	0.000992	0.00454	CcSEcCtD
Levothyroxine—Dyspnoea—Progesterone—uterine cancer	0.000983	0.0045	CcSEcCtD
Levothyroxine—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000983	0.0045	CcSEcCtD
Levothyroxine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000975	0.00446	CcSEcCtD
Levothyroxine—Alopecia—Dactinomycin—uterine cancer	0.00097	0.00443	CcSEcCtD
Levothyroxine—Sweating increased—Etoposide—uterine cancer	0.000966	0.00442	CcSEcCtD
Levothyroxine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000966	0.00442	CcSEcCtD
Levothyroxine—Fatigue—Progesterone—uterine cancer	0.000951	0.00435	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00091	0.00416	CcSEcCtD
Levothyroxine—Feeling abnormal—Progesterone—uterine cancer	0.000909	0.00416	CcSEcCtD
Levothyroxine—CYP2C8—vagina—uterine cancer	0.000905	0.00638	CbGeAlD
Levothyroxine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000904	0.00413	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Progesterone—uterine cancer	0.000902	0.00412	CcSEcCtD
Levothyroxine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000891	0.00407	CcSEcCtD
Levothyroxine—Urticaria—Progesterone—uterine cancer	0.000876	0.00401	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Etoposide—uterine cancer	0.000872	0.00399	CcSEcCtD
Levothyroxine—Body temperature increased—Progesterone—uterine cancer	0.000872	0.00399	CcSEcCtD
Levothyroxine—Abdominal pain—Progesterone—uterine cancer	0.000872	0.00399	CcSEcCtD
Levothyroxine—Myocardial infarction—Etoposide—uterine cancer	0.000867	0.00397	CcSEcCtD
Levothyroxine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000862	0.00394	CcSEcCtD
Levothyroxine—CYP3A4—renal system—uterine cancer	0.000846	0.00597	CbGeAlD
Levothyroxine—ALB—lymph node—uterine cancer	0.000833	0.00587	CbGeAlD
Levothyroxine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000824	0.00377	CcSEcCtD
Levothyroxine—ABCB1—myometrium—uterine cancer	0.000823	0.0058	CbGeAlD
Levothyroxine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000817	0.00374	CcSEcCtD
Levothyroxine—Coma—Epirubicin—uterine cancer	0.00081	0.0037	CcSEcCtD
Levothyroxine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000794	0.00363	CcSEcCtD
Levothyroxine—Asthenia—Progesterone—uterine cancer	0.000791	0.00362	CcSEcCtD
Levothyroxine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00079	0.00361	CcSEcCtD
Levothyroxine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00079	0.00361	CcSEcCtD
Levothyroxine—Pruritus—Progesterone—uterine cancer	0.00078	0.00357	CcSEcCtD
Levothyroxine—Diarrhoea—Progesterone—uterine cancer	0.000755	0.00345	CcSEcCtD
Levothyroxine—Coma—Doxorubicin—uterine cancer	0.000749	0.00343	CcSEcCtD
Levothyroxine—Flushing—Etoposide—uterine cancer	0.000737	0.00337	CcSEcCtD
Levothyroxine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000717	0.00328	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00071	0.00325	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Epirubicin—uterine cancer	0.000709	0.00325	CcSEcCtD
Levothyroxine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000707	0.00323	CcSEcCtD
Levothyroxine—Alopecia—Etoposide—uterine cancer	0.000702	0.00321	CcSEcCtD
Levothyroxine—Vomiting—Progesterone—uterine cancer	0.000701	0.00321	CcSEcCtD
Levothyroxine—Rash—Progesterone—uterine cancer	0.000695	0.00318	CcSEcCtD
Levothyroxine—Dermatitis—Progesterone—uterine cancer	0.000695	0.00318	CcSEcCtD
Levothyroxine—Headache—Progesterone—uterine cancer	0.000691	0.00316	CcSEcCtD
Levothyroxine—Increased appetite—Epirubicin—uterine cancer	0.000685	0.00313	CcSEcCtD
Levothyroxine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000684	0.00313	CcSEcCtD
Levothyroxine—CYP3A4—female reproductive system—uterine cancer	0.000678	0.00478	CbGeAlD
Levothyroxine—Fatigue—Dactinomycin—uterine cancer	0.000672	0.00307	CcSEcCtD
Levothyroxine—Cardiac failure—Epirubicin—uterine cancer	0.000659	0.00302	CcSEcCtD
Levothyroxine—Hypoglycaemia—Epirubicin—uterine cancer	0.000659	0.00302	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000656	0.003	CcSEcCtD
Levothyroxine—Nausea—Progesterone—uterine cancer	0.000655	0.003	CcSEcCtD
Levothyroxine—ABCB1—epithelium—uterine cancer	0.000646	0.00455	CbGeAlD
Levothyroxine—Feeling abnormal—Dactinomycin—uterine cancer	0.000642	0.00294	CcSEcCtD
Levothyroxine—ABCB1—uterine cervix—uterine cancer	0.00064	0.00451	CbGeAlD
Levothyroxine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000637	0.00292	CcSEcCtD
Levothyroxine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000635	0.00291	CcSEcCtD
Levothyroxine—Increased appetite—Doxorubicin—uterine cancer	0.000634	0.0029	CcSEcCtD
Levothyroxine—Affect lability—Epirubicin—uterine cancer	0.000633	0.0029	CcSEcCtD
Levothyroxine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00063	0.00288	CcSEcCtD
Levothyroxine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00063	0.00288	CcSEcCtD
Levothyroxine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000626	0.00286	CcSEcCtD
Levothyroxine—Body temperature increased—Dactinomycin—uterine cancer	0.000616	0.00282	CcSEcCtD
Levothyroxine—Abdominal pain—Dactinomycin—uterine cancer	0.000616	0.00282	CcSEcCtD
Levothyroxine—Cardiac arrest—Epirubicin—uterine cancer	0.000612	0.0028	CcSEcCtD
Levothyroxine—ABCB1—decidua—uterine cancer	0.00061	0.0043	CbGeAlD
Levothyroxine—Hypoglycaemia—Doxorubicin—uterine cancer	0.00061	0.00279	CcSEcCtD
Levothyroxine—Cardiac failure—Doxorubicin—uterine cancer	0.00061	0.00279	CcSEcCtD
Levothyroxine—Mood swings—Epirubicin—uterine cancer	0.00061	0.00279	CcSEcCtD
Levothyroxine—ABCB1—renal system—uterine cancer	0.000599	0.00422	CbGeAlD
Levothyroxine—Convulsion—Etoposide—uterine cancer	0.000599	0.00274	CcSEcCtD
Levothyroxine—Dehydration—Epirubicin—uterine cancer	0.000598	0.00274	CcSEcCtD
Levothyroxine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000594	0.00271	CcSEcCtD
Levothyroxine—Affect lability—Doxorubicin—uterine cancer	0.000586	0.00268	CcSEcCtD
Levothyroxine—ABCB1—endometrium—uterine cancer	0.000579	0.00408	CbGeAlD
Levothyroxine—Confusional state—Etoposide—uterine cancer	0.000569	0.0026	CcSEcCtD
Levothyroxine—Muscular weakness—Epirubicin—uterine cancer	0.000567	0.0026	CcSEcCtD
Levothyroxine—Cardiac arrest—Doxorubicin—uterine cancer	0.000566	0.00259	CcSEcCtD
Levothyroxine—Mood swings—Doxorubicin—uterine cancer	0.000564	0.00258	CcSEcCtD
Levothyroxine—ABCB1—mammalian vulva—uterine cancer	0.00056	0.00395	CbGeAlD
Levothyroxine—Asthenia—Dactinomycin—uterine cancer	0.000559	0.00256	CcSEcCtD
Levothyroxine—Dysphagia—Epirubicin—uterine cancer	0.000556	0.00254	CcSEcCtD
Levothyroxine—Dehydration—Doxorubicin—uterine cancer	0.000554	0.00253	CcSEcCtD
Levothyroxine—Tachycardia—Etoposide—uterine cancer	0.000551	0.00252	CcSEcCtD
Levothyroxine—Hyperhidrosis—Etoposide—uterine cancer	0.000545	0.00249	CcSEcCtD
Levothyroxine—Angina pectoris—Epirubicin—uterine cancer	0.000542	0.00248	CcSEcCtD
Levothyroxine—ABCB1—uterus—uterine cancer	0.000534	0.00376	CbGeAlD
Levothyroxine—Diarrhoea—Dactinomycin—uterine cancer	0.000533	0.00244	CcSEcCtD
Levothyroxine—Muscular weakness—Doxorubicin—uterine cancer	0.000525	0.0024	CcSEcCtD
Levothyroxine—Dysphagia—Doxorubicin—uterine cancer	0.000515	0.00235	CcSEcCtD
Levothyroxine—Weight decreased—Epirubicin—uterine cancer	0.000503	0.0023	CcSEcCtD
Levothyroxine—Dyspnoea—Etoposide—uterine cancer	0.000503	0.0023	CcSEcCtD
Levothyroxine—Angina pectoris—Doxorubicin—uterine cancer	0.000501	0.00229	CcSEcCtD
Levothyroxine—Vomiting—Dactinomycin—uterine cancer	0.000496	0.00227	CcSEcCtD
Levothyroxine—Rash—Dactinomycin—uterine cancer	0.000491	0.00225	CcSEcCtD
Levothyroxine—Fatigue—Etoposide—uterine cancer	0.000486	0.00222	CcSEcCtD
Levothyroxine—ABCB1—female reproductive system—uterine cancer	0.00048	0.00338	CbGeAlD
Levothyroxine—Sweating—Epirubicin—uterine cancer	0.000475	0.00217	CcSEcCtD
Levothyroxine—Weight decreased—Doxorubicin—uterine cancer	0.000466	0.00213	CcSEcCtD
Levothyroxine—Feeling abnormal—Etoposide—uterine cancer	0.000465	0.00213	CcSEcCtD
Levothyroxine—Nausea—Dactinomycin—uterine cancer	0.000463	0.00212	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Etoposide—uterine cancer	0.000461	0.00211	CcSEcCtD
Levothyroxine—Urticaria—Etoposide—uterine cancer	0.000448	0.00205	CcSEcCtD
Levothyroxine—Abdominal pain—Etoposide—uterine cancer	0.000446	0.00204	CcSEcCtD
Levothyroxine—Body temperature increased—Etoposide—uterine cancer	0.000446	0.00204	CcSEcCtD
Levothyroxine—Sweating—Doxorubicin—uterine cancer	0.00044	0.00201	CcSEcCtD
Levothyroxine—ABCB1—female gonad—uterine cancer	0.000437	0.00308	CbGeAlD
Levothyroxine—ABCB1—vagina—uterine cancer	0.000434	0.00306	CbGeAlD
Levothyroxine—Flushing—Epirubicin—uterine cancer	0.000413	0.00189	CcSEcCtD
Levothyroxine—Asthenia—Etoposide—uterine cancer	0.000405	0.00185	CcSEcCtD
Levothyroxine—Pruritus—Etoposide—uterine cancer	0.000399	0.00183	CcSEcCtD
Levothyroxine—Arrhythmia—Epirubicin—uterine cancer	0.000398	0.00182	CcSEcCtD
Levothyroxine—Alopecia—Epirubicin—uterine cancer	0.000393	0.0018	CcSEcCtD
Levothyroxine—Diarrhoea—Etoposide—uterine cancer	0.000386	0.00177	CcSEcCtD
Levothyroxine—Flushing—Doxorubicin—uterine cancer	0.000382	0.00175	CcSEcCtD
Levothyroxine—Tension—Epirubicin—uterine cancer	0.00038	0.00174	CcSEcCtD
Levothyroxine—Nervousness—Epirubicin—uterine cancer	0.000376	0.00172	CcSEcCtD
Levothyroxine—Arrhythmia—Doxorubicin—uterine cancer	0.000368	0.00168	CcSEcCtD
Levothyroxine—Alopecia—Doxorubicin—uterine cancer	0.000364	0.00166	CcSEcCtD
Levothyroxine—Vomiting—Etoposide—uterine cancer	0.000359	0.00164	CcSEcCtD
Levothyroxine—Agitation—Epirubicin—uterine cancer	0.000356	0.00163	CcSEcCtD
Levothyroxine—Rash—Etoposide—uterine cancer	0.000356	0.00163	CcSEcCtD
Levothyroxine—Dermatitis—Etoposide—uterine cancer	0.000355	0.00163	CcSEcCtD
Levothyroxine—Headache—Etoposide—uterine cancer	0.000353	0.00162	CcSEcCtD
Levothyroxine—Tension—Doxorubicin—uterine cancer	0.000352	0.00161	CcSEcCtD
Levothyroxine—Nervousness—Doxorubicin—uterine cancer	0.000348	0.00159	CcSEcCtD
Levothyroxine—Palpitations—Epirubicin—uterine cancer	0.000342	0.00157	CcSEcCtD
Levothyroxine—Convulsion—Epirubicin—uterine cancer	0.000336	0.00154	CcSEcCtD
Levothyroxine—Nausea—Etoposide—uterine cancer	0.000335	0.00153	CcSEcCtD
Levothyroxine—Arthralgia—Epirubicin—uterine cancer	0.00033	0.00151	CcSEcCtD
Levothyroxine—Agitation—Doxorubicin—uterine cancer	0.000329	0.00151	CcSEcCtD
Levothyroxine—Anxiety—Epirubicin—uterine cancer	0.000329	0.0015	CcSEcCtD
Levothyroxine—Confusional state—Epirubicin—uterine cancer	0.000319	0.00146	CcSEcCtD
Levothyroxine—Palpitations—Doxorubicin—uterine cancer	0.000317	0.00145	CcSEcCtD
Levothyroxine—Shock—Epirubicin—uterine cancer	0.000311	0.00142	CcSEcCtD
Levothyroxine—Convulsion—Doxorubicin—uterine cancer	0.000311	0.00142	CcSEcCtD
Levothyroxine—Tachycardia—Epirubicin—uterine cancer	0.000309	0.00141	CcSEcCtD
Levothyroxine—Hyperhidrosis—Epirubicin—uterine cancer	0.000306	0.0014	CcSEcCtD
Levothyroxine—Arthralgia—Doxorubicin—uterine cancer	0.000305	0.0014	CcSEcCtD
Levothyroxine—Anxiety—Doxorubicin—uterine cancer	0.000304	0.00139	CcSEcCtD
Levothyroxine—Confusional state—Doxorubicin—uterine cancer	0.000295	0.00135	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000288	0.00132	CcSEcCtD
Levothyroxine—Shock—Doxorubicin—uterine cancer	0.000288	0.00132	CcSEcCtD
Levothyroxine—Insomnia—Epirubicin—uterine cancer	0.000286	0.00131	CcSEcCtD
Levothyroxine—Tachycardia—Doxorubicin—uterine cancer	0.000286	0.00131	CcSEcCtD
Levothyroxine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000283	0.00129	CcSEcCtD
Levothyroxine—Dyspnoea—Epirubicin—uterine cancer	0.000282	0.00129	CcSEcCtD
Levothyroxine—ABCB1—lymph node—uterine cancer	0.000281	0.00198	CbGeAlD
Levothyroxine—Fatigue—Epirubicin—uterine cancer	0.000273	0.00125	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000267	0.00122	CcSEcCtD
Levothyroxine—Insomnia—Doxorubicin—uterine cancer	0.000265	0.00121	CcSEcCtD
Levothyroxine—Dyspnoea—Doxorubicin—uterine cancer	0.000261	0.00119	CcSEcCtD
Levothyroxine—Feeling abnormal—Epirubicin—uterine cancer	0.000261	0.00119	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000259	0.00118	CcSEcCtD
Levothyroxine—Fatigue—Doxorubicin—uterine cancer	0.000252	0.00115	CcSEcCtD
Levothyroxine—Urticaria—Epirubicin—uterine cancer	0.000251	0.00115	CcSEcCtD
Levothyroxine—Body temperature increased—Epirubicin—uterine cancer	0.00025	0.00114	CcSEcCtD
Levothyroxine—Abdominal pain—Epirubicin—uterine cancer	0.00025	0.00114	CcSEcCtD
Levothyroxine—Feeling abnormal—Doxorubicin—uterine cancer	0.000241	0.0011	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000239	0.00109	CcSEcCtD
Levothyroxine—Urticaria—Doxorubicin—uterine cancer	0.000232	0.00106	CcSEcCtD
Levothyroxine—Abdominal pain—Doxorubicin—uterine cancer	0.000231	0.00106	CcSEcCtD
Levothyroxine—Body temperature increased—Doxorubicin—uterine cancer	0.000231	0.00106	CcSEcCtD
Levothyroxine—Asthenia—Epirubicin—uterine cancer	0.000227	0.00104	CcSEcCtD
Levothyroxine—Pruritus—Epirubicin—uterine cancer	0.000224	0.00102	CcSEcCtD
Levothyroxine—Diarrhoea—Epirubicin—uterine cancer	0.000216	0.00099	CcSEcCtD
Levothyroxine—Asthenia—Doxorubicin—uterine cancer	0.00021	0.00096	CcSEcCtD
Levothyroxine—Pruritus—Doxorubicin—uterine cancer	0.000207	0.000947	CcSEcCtD
Levothyroxine—Vomiting—Epirubicin—uterine cancer	0.000201	0.00092	CcSEcCtD
Levothyroxine—Diarrhoea—Doxorubicin—uterine cancer	0.0002	0.000916	CcSEcCtD
Levothyroxine—Rash—Epirubicin—uterine cancer	0.000199	0.000912	CcSEcCtD
Levothyroxine—Dermatitis—Epirubicin—uterine cancer	0.000199	0.000911	CcSEcCtD
Levothyroxine—Headache—Epirubicin—uterine cancer	0.000198	0.000906	CcSEcCtD
Levothyroxine—Nausea—Epirubicin—uterine cancer	0.000188	0.000859	CcSEcCtD
Levothyroxine—Vomiting—Doxorubicin—uterine cancer	0.000186	0.000851	CcSEcCtD
Levothyroxine—Rash—Doxorubicin—uterine cancer	0.000184	0.000844	CcSEcCtD
Levothyroxine—Dermatitis—Doxorubicin—uterine cancer	0.000184	0.000843	CcSEcCtD
Levothyroxine—Headache—Doxorubicin—uterine cancer	0.000183	0.000838	CcSEcCtD
Levothyroxine—Nausea—Doxorubicin—uterine cancer	0.000174	0.000795	CcSEcCtD
Levothyroxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.00011	0.00118	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—AKR1B1—uterine cancer	0.000109	0.00118	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—STAR—uterine cancer	0.000109	0.00118	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000109	0.00117	CbGpPWpGaD
Levothyroxine—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	0.000109	0.00117	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—CCL2—uterine cancer	0.000109	0.00117	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—AKR1C1—uterine cancer	0.000108	0.00117	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000108	0.00116	CbGpPWpGaD
Levothyroxine—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	0.000107	0.00115	CbGpPWpGaD
Levothyroxine—TTR—Disease—FBXW7—uterine cancer	0.000106	0.00114	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000103	0.00111	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—SRD5A2—uterine cancer	0.000102	0.00109	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—NDUFB11—uterine cancer	0.000102	0.00109	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	9.86e-05	0.00106	CbGpPWpGaD
Levothyroxine—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	9.58e-05	0.00103	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	9.58e-05	0.00103	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	9.47e-05	0.00102	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	9.47e-05	0.00102	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	9.42e-05	0.00101	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—STAR—uterine cancer	9.42e-05	0.00101	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—ESR1—uterine cancer	9.36e-05	0.00101	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—ESR1—uterine cancer	9.36e-05	0.00101	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	9.31e-05	0.001	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—EP300—uterine cancer	9.11e-05	0.000982	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—ABCC9—uterine cancer	8.95e-05	0.000964	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	8.7e-05	0.000937	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—VEGFA—uterine cancer	8.63e-05	0.00093	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—AKR1B1—uterine cancer	8.58e-05	0.000924	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—STAR—uterine cancer	8.58e-05	0.000924	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—POLD1—uterine cancer	8.57e-05	0.000923	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—NRAS—uterine cancer	8.53e-05	0.000918	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	8.48e-05	0.000914	CbGpPWpGaD
Levothyroxine—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	8.41e-05	0.000906	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—AKR1C3—uterine cancer	8.34e-05	0.000898	CbGpPWpGaD
Levothyroxine—TTR—Disease—CDKN2B—uterine cancer	8.31e-05	0.000895	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—CXCL8—uterine cancer	8.19e-05	0.000883	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PGR—uterine cancer	8.12e-05	0.000875	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	8.11e-05	0.000874	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—AKR1C1—uterine cancer	8.02e-05	0.000864	CbGpPWpGaD
Levothyroxine—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	7.92e-05	0.000853	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	7.85e-05	0.000845	CbGpPWpGaD
Levothyroxine—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	7.81e-05	0.000841	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	7.8e-05	0.00084	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—YWHAE—uterine cancer	7.75e-05	0.000835	CbGpPWpGaD
Levothyroxine—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	7.74e-05	0.000834	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	7.69e-05	0.000828	CbGpPWpGaD
Levothyroxine—TTR—Disease—SMAD3—uterine cancer	7.59e-05	0.000817	CbGpPWpGaD
Levothyroxine—ALB—Platelet degranulation—VEGFA—uterine cancer	7.52e-05	0.00081	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—FBXW7—uterine cancer	7.43e-05	0.0008	CbGpPWpGaD
Levothyroxine—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	7.38e-05	0.000795	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—STAR—uterine cancer	7.34e-05	0.000791	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—AKR1B1—uterine cancer	7.34e-05	0.000791	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—KRAS—uterine cancer	7.34e-05	0.00079	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	7.26e-05	0.000781	CbGpPWpGaD
Levothyroxine—TTR—Disease—FGFR2—uterine cancer	7.24e-05	0.00078	CbGpPWpGaD
Levothyroxine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	7.16e-05	0.000772	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—RRM2—uterine cancer	7.15e-05	0.00077	CbGpPWpGaD
Levothyroxine—TTR—Disease—MTHFR—uterine cancer	6.97e-05	0.000751	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	6.95e-05	0.000749	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—DCN—uterine cancer	6.94e-05	0.000747	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	6.91e-05	0.000744	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—PIK3CA—uterine cancer	6.74e-05	0.000726	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—POLD1—uterine cancer	6.74e-05	0.000725	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—VEGFA—uterine cancer	6.66e-05	0.000717	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—TP53—uterine cancer	6.63e-05	0.000714	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CYP11A1—uterine cancer	6.54e-05	0.000704	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—TP53—uterine cancer	6.52e-05	0.000702	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—STK11—uterine cancer	6.49e-05	0.000699	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—AKR1C1—uterine cancer	6.3e-05	0.000679	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—HRAS—uterine cancer	6.24e-05	0.000672	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—AKR1C3—uterine cancer	6.17e-05	0.000665	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—SOCS3—uterine cancer	6.08e-05	0.000655	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NDUFB11—uterine cancer	5.83e-05	0.000628	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—SRD5A2—uterine cancer	5.83e-05	0.000628	CbGpPWpGaD
Levothyroxine—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	5.83e-05	0.000628	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CDKN2B—uterine cancer	5.82e-05	0.000627	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IRF1—uterine cancer	5.81e-05	0.000626	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	5.81e-05	0.000626	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NDUFB11—uterine cancer	5.8e-05	0.000625	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—SRD5A2—uterine cancer	5.8e-05	0.000625	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—POLD1—uterine cancer	5.76e-05	0.00062	CbGpPWpGaD
Levothyroxine—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	5.75e-05	0.000619	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.67e-05	0.00061	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IGF1R—uterine cancer	5.65e-05	0.000609	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.63e-05	0.000607	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—RRM2—uterine cancer	5.62e-05	0.000605	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—AKT1—uterine cancer	5.51e-05	0.000593	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—DCN—uterine cancer	5.45e-05	0.000587	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—AKR1C1—uterine cancer	5.39e-05	0.00058	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.35e-05	0.000576	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.32e-05	0.000573	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—SMAD3—uterine cancer	5.32e-05	0.000572	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CYP11A1—uterine cancer	5.14e-05	0.000553	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SRD5A2—uterine cancer	5.08e-05	0.000547	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NDUFB11—uterine cancer	5.08e-05	0.000547	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—FGFR2—uterine cancer	5.07e-05	0.000546	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	4.9e-05	0.000528	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—AKR1C3—uterine cancer	4.85e-05	0.000522	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—STK11—uterine cancer	4.81e-05	0.000518	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CYP19A1—uterine cancer	4.81e-05	0.000518	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—RRM2—uterine cancer	4.8e-05	0.000517	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—DCN—uterine cancer	4.66e-05	0.000502	CbGpPWpGaD
Levothyroxine—TTR—Disease—ERBB2—uterine cancer	4.55e-05	0.00049	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.51e-05	0.000486	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CYP11A1—uterine cancer	4.39e-05	0.000473	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—ESR1—uterine cancer	4.34e-05	0.000467	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.31e-05	0.000464	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	4.26e-05	0.000459	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—AKR1B1—uterine cancer	4.22e-05	0.000454	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—STAR—uterine cancer	4.22e-05	0.000454	CbGpPWpGaD
Levothyroxine—TTR—Disease—CDKN1B—uterine cancer	4.21e-05	0.000453	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—STAR—uterine cancer	4.19e-05	0.000452	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—AKR1B1—uterine cancer	4.19e-05	0.000452	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.17e-05	0.000449	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—AKR1C3—uterine cancer	4.15e-05	0.000447	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.15e-05	0.000446	CbGpPWpGaD
Levothyroxine—TTR—Disease—CTNNB1—uterine cancer	3.98e-05	0.000428	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	3.95e-05	0.000425	CbGpPWpGaD
Levothyroxine—TTR—Disease—PTEN—uterine cancer	3.88e-05	0.000418	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCL2—uterine cancer	3.82e-05	0.000411	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—STK11—uterine cancer	3.78e-05	0.000407	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CYP19A1—uterine cancer	3.78e-05	0.000407	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	3.73e-05	0.000402	CbGpPWpGaD
Levothyroxine—TTR—Disease—EP300—uterine cancer	3.7e-05	0.000398	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—AKR1B1—uterine cancer	3.67e-05	0.000396	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—STAR—uterine cancer	3.67e-05	0.000396	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	3.64e-05	0.000392	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—MTHFR—uterine cancer	3.61e-05	0.000389	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.55e-05	0.000382	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	3.47e-05	0.000373	CbGpPWpGaD
Levothyroxine—TTR—Disease—NRAS—uterine cancer	3.46e-05	0.000373	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.38e-05	0.000364	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—AKT1—uterine cancer	3.38e-05	0.000364	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—AKT1—uterine cancer	3.38e-05	0.000364	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	3.34e-05	0.000359	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—POLD1—uterine cancer	3.31e-05	0.000356	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—POLD1—uterine cancer	3.29e-05	0.000354	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	3.28e-05	0.000354	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—STK11—uterine cancer	3.23e-05	0.000348	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CYP19A1—uterine cancer	3.23e-05	0.000348	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.18e-05	0.000343	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—ERBB2—uterine cancer	3.18e-05	0.000343	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SRD5A2—uterine cancer	3.13e-05	0.000337	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NDUFB11—uterine cancer	3.13e-05	0.000337	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—AKR1C1—uterine cancer	3.1e-05	0.000333	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—AKR1C1—uterine cancer	3.08e-05	0.000332	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.03e-05	0.000327	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CXCL8—uterine cancer	3.02e-05	0.000325	CbGpPWpGaD
Levothyroxine—TTR—Disease—KRAS—uterine cancer	2.98e-05	0.000321	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CDKN1B—uterine cancer	2.95e-05	0.000318	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.89e-05	0.000312	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—POLD1—uterine cancer	2.88e-05	0.000311	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—MTHFR—uterine cancer	2.84e-05	0.000306	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	2.79e-05	0.000301	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CTNNB1—uterine cancer	2.79e-05	0.0003	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—RRM2—uterine cancer	2.76e-05	0.000297	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—RRM2—uterine cancer	2.74e-05	0.000295	CbGpPWpGaD
Levothyroxine—TTR—Disease—PIK3CA—uterine cancer	2.74e-05	0.000295	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PTEN—uterine cancer	2.71e-05	0.000292	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—AKR1C1—uterine cancer	2.7e-05	0.00029	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—DCN—uterine cancer	2.68e-05	0.000288	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—DCN—uterine cancer	2.66e-05	0.000287	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	2.61e-05	0.000281	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EP300—uterine cancer	2.59e-05	0.000279	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	2.57e-05	0.000276	CbGpPWpGaD
Levothyroxine—TTR—Disease—HRAS—uterine cancer	2.53e-05	0.000273	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP11A1—uterine cancer	2.52e-05	0.000272	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP11A1—uterine cancer	2.51e-05	0.00027	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.5e-05	0.000269	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.48e-05	0.000267	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—VEGFA—uterine cancer	2.45e-05	0.000264	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—MTHFR—uterine cancer	2.43e-05	0.000262	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—NRAS—uterine cancer	2.42e-05	0.000261	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—RRM2—uterine cancer	2.4e-05	0.000259	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—AKR1C3—uterine cancer	2.38e-05	0.000257	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—AKR1C3—uterine cancer	2.37e-05	0.000255	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—DCN—uterine cancer	2.33e-05	0.000251	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—STAR—uterine cancer	2.26e-05	0.000244	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.26e-05	0.000244	CbGpPWpGaD
Levothyroxine—TTR—Disease—AKT1—uterine cancer	2.23e-05	0.000241	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP11A1—uterine cancer	2.2e-05	0.000237	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.14e-05	0.00023	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	2.13e-05	0.000229	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.1e-05	0.000226	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—KRAS—uterine cancer	2.08e-05	0.000225	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—AKR1C3—uterine cancer	2.08e-05	0.000224	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTEN—uterine cancer	2.01e-05	0.000217	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—EP300—uterine cancer	1.92e-05	0.000206	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PIK3CA—uterine cancer	1.92e-05	0.000206	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—STK11—uterine cancer	1.86e-05	0.0002	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP19A1—uterine cancer	1.86e-05	0.0002	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TP53—uterine cancer	1.85e-05	0.0002	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—STK11—uterine cancer	1.85e-05	0.000199	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP19A1—uterine cancer	1.85e-05	0.000199	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—EP300—uterine cancer	1.82e-05	0.000196	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—POLD1—uterine cancer	1.78e-05	0.000191	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HRAS—uterine cancer	1.77e-05	0.000191	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.74e-05	0.000188	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.73e-05	0.000187	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—VEGFA—uterine cancer	1.72e-05	0.000185	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—NRAS—uterine cancer	1.7e-05	0.000183	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.66e-05	0.000179	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.66e-05	0.000179	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.65e-05	0.000178	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—STK11—uterine cancer	1.62e-05	0.000174	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP19A1—uterine cancer	1.62e-05	0.000174	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTEN—uterine cancer	1.58e-05	0.00017	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—AKT1—uterine cancer	1.56e-05	0.000169	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—EP300—uterine cancer	1.51e-05	0.000162	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—RRM2—uterine cancer	1.48e-05	0.00016	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—KRAS—uterine cancer	1.46e-05	0.000157	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—DCN—uterine cancer	1.44e-05	0.000155	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CA—uterine cancer	1.42e-05	0.000153	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—MTHFR—uterine cancer	1.4e-05	0.00015	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—MTHFR—uterine cancer	1.39e-05	0.000149	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.35e-05	0.000146	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTEN—uterine cancer	1.35e-05	0.000145	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CA—uterine cancer	1.34e-05	0.000145	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TP53—uterine cancer	1.3e-05	0.00014	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—EP300—uterine cancer	1.29e-05	0.000139	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.28e-05	0.000138	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—HRAS—uterine cancer	1.24e-05	0.000134	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.23e-05	0.000132	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.22e-05	0.000132	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—MTHFR—uterine cancer	1.22e-05	0.000131	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—AKT1—uterine cancer	1.16e-05	0.000125	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CA—uterine cancer	1.11e-05	0.00012	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—AKT1—uterine cancer	1.1e-05	0.000118	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—STK11—uterine cancer	9.97e-06	0.000107	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP19A1—uterine cancer	9.97e-06	0.000107	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CA—uterine cancer	9.53e-06	0.000103	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—AKT1—uterine cancer	9.1e-06	9.8e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—AKT1—uterine cancer	7.79e-06	8.38e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTEN—uterine cancer	7.76e-06	8.36e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTEN—uterine cancer	7.72e-06	8.31e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—MTHFR—uterine cancer	7.49e-06	8.07e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—EP300—uterine cancer	7.4e-06	7.97e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—EP300—uterine cancer	7.36e-06	7.93e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTEN—uterine cancer	6.76e-06	7.28e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—EP300—uterine cancer	6.45e-06	6.95e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CA—uterine cancer	5.48e-06	5.9e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CA—uterine cancer	5.44e-06	5.86e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CA—uterine cancer	4.77e-06	5.14e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—AKT1—uterine cancer	4.47e-06	4.82e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—AKT1—uterine cancer	4.45e-06	4.79e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTEN—uterine cancer	4.17e-06	4.49e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—EP300—uterine cancer	3.97e-06	4.28e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—AKT1—uterine cancer	3.9e-06	4.2e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.94e-06	3.17e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—AKT1—uterine cancer	2.4e-06	2.59e-05	CbGpPWpGaD
